| Primary |
| Product Used For Unknown Indication |
26.3% |
| Bipolar Disorder |
21.3% |
| Convulsion |
12.5% |
| Agitation |
7.5% |
| Hostility |
6.3% |
| Bipolar I Disorder |
3.8% |
| Epilepsy |
3.8% |
| Schizoaffective Disorder |
3.8% |
| Affective Disorder |
2.5% |
| Headache |
1.3% |
| Intractable Epilepsy |
1.3% |
| Mania |
1.3% |
| Pain |
1.3% |
| Panic Disorder |
1.3% |
| Panic Reaction |
1.3% |
| Schizo-affective Type Schizophrenia, Chronic State |
1.3% |
| Schizophrenia, Paranoid Type |
1.3% |
| Status Epilepticus |
1.3% |
| Upper Respiratory Tract Infection |
1.3% |
|
| Toxicity To Various Agents |
37.5% |
| Convulsion |
7.5% |
| Hyperammonaemia |
5.0% |
| Mental Status Changes |
5.0% |
| Product Substitution Issue |
5.0% |
| White Blood Cell Count Increased |
5.0% |
| Ammonia Increased |
2.5% |
| Completed Suicide |
2.5% |
| Delusion |
2.5% |
| Dizziness |
2.5% |
| Drooling |
2.5% |
| Drug Ineffective |
2.5% |
| Dystonia |
2.5% |
| Fluid Retention |
2.5% |
| Flushing |
2.5% |
| Hallucination, Visual |
2.5% |
| Hyperammonaemic Encephalopathy |
2.5% |
| Lipase Increased |
2.5% |
| Mental Disorder |
2.5% |
| Metabolic Acidosis |
2.5% |
|
| Secondary |
| Insomnia |
13.5% |
| Depression |
13.1% |
| Schizophrenia |
13.1% |
| Delusional Disorder, Unspecified Type |
12.1% |
| Psychotic Disorder |
12.1% |
| Product Used For Unknown Indication |
7.4% |
| Agitation |
6.4% |
| Bipolar Disorder |
3.5% |
| Hostility |
3.5% |
| Antiretroviral Therapy |
2.5% |
| Convulsion |
2.5% |
| Mania |
2.1% |
| Suicide Attempt |
1.8% |
| Atrial Fibrillation |
1.4% |
| Depressive Symptom |
1.4% |
| Anxiety |
0.7% |
| Coronary Artery Disease |
0.7% |
| Delusion |
0.7% |
| Distractibility |
0.7% |
| Disturbance In Attention |
0.7% |
|
| Weight Increased |
16.7% |
| Toxicity To Various Agents |
13.3% |
| Lipase Increased |
6.7% |
| Pancreatitis Acute |
6.7% |
| Psychotic Disorder |
6.7% |
| Choking |
3.3% |
| Completed Suicide |
3.3% |
| Convulsion |
3.3% |
| Drug Hypersensitivity |
3.3% |
| Gait Disturbance |
3.3% |
| Hepatitis Acute |
3.3% |
| Multiple Drug Overdose Intentional |
3.3% |
| Oedema Peripheral |
3.3% |
| Off Label Use |
3.3% |
| Pleurothotonus |
3.3% |
| Product Substitution Issue |
3.3% |
| Schizoaffective Disorder |
3.3% |
| Skin Ulcer |
3.3% |
| Suicidal Ideation |
3.3% |
| Tardive Dyskinesia |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.8% |
| Depression |
12.2% |
| Bipolar Disorder |
11.1% |
| Anxiety |
7.0% |
| Sleep Disorder |
5.7% |
| Schizophrenia |
4.9% |
| Convulsion |
4.1% |
| Epilepsy |
2.7% |
| Hypertension |
2.6% |
| Pain |
2.6% |
| Affective Disorder |
2.5% |
| Arthritis |
2.3% |
| Psychotic Disorder |
2.2% |
| Rheumatoid Arthritis |
2.1% |
| Post-traumatic Stress Disorder |
1.9% |
| Schizoaffective Disorder |
1.8% |
| Schizophrenia, Paranoid Type |
1.8% |
| Crohn's Disease |
1.6% |
| Personality Disorder |
1.6% |
| Fibromyalgia |
1.5% |
|
| Convulsion |
9.9% |
| Death |
8.5% |
| Tremor |
8.5% |
| Vomiting |
8.5% |
| Weight Decreased |
8.5% |
| Weight Increased |
8.5% |
| Drug Ineffective |
5.6% |
| Granulocytopenia |
4.2% |
| Leukopenia |
4.2% |
| Pyrexia |
4.2% |
| Uterine Perforation |
4.2% |
| Atrial Fibrillation |
2.8% |
| Atrioventricular Block Second Degree |
2.8% |
| Blood Glucose Increased |
2.8% |
| International Normalised Ratio Increased |
2.8% |
| Irritability |
2.8% |
| Migraine |
2.8% |
| Multiple Sclerosis |
2.8% |
| Pain |
2.8% |
| Paraphilia |
2.8% |
|
